https://www.gempharmatech.com/ 2026-07-26T05:16:32+00:00 daily 1.0000 https://www.gempharmatech.com/insights/events 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/genetically-engineered-models 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/oncology 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/humanized-immune-system-mice 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/tumor-cell-lines 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/patient-derived-xenograft-pdx 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/metabolic-diseases 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/obesity 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/diabetes 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/metabolic-dysfunction-associated-steatohepatitis-mash 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/osteoporosis 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/diabetic-nephropathy 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/sarcopenia 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/hyperuricemia 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/inflammatory-and-autoimmune-diseases 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/systemic-lupus-erythematosus-sle 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/rheumatoid-arthritis-ra 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/systemic-sclerosis 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/sjogren-s-syndrome 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/psoriasis-4 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/autosomal-dominant-polycystic-kidney-disease-adpkd-2 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/autosomal-dominant-polycystic-kidney-disease-adpkd 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/c3-glomerulopathy-c3g 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/iga-nephropathy-igan 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/alport-syndrome 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/asthma 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/inflammatory-bowel-disease 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/multiple-sclerosis 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/myasthenia-gravis 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/cardiovascular-diseases 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/heart-failure 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/heart-failure-with-preserved-ejection-fraction-hfpef 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/heart-failure-with-reduced-ejection-fraction-hfref 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/cardiorenal-syndrome 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/coronary-heart-disease-chd 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/cardiomyopathy 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/thrombosis 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/neurological-diseases 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/ad 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/als 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/bbb 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/depression-mouse-models 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/dmd 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/hd 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/pain-mouse-models 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/pd 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/attr 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/respiratory 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/infectious 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/rare-disease 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/gut-microbiota-research-service 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/immune-checkpoint-inhibitors 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/adc 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/In-vivo-car-t 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/tce 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/preclinical-pathology-services-2 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/preclinical-pk-pd-services 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/molecular-testing 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/in-vitro-services 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/flow-cytometry-services 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/imaging-and-analysis 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/preclinical-service/behavioral-analysis 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/webinars/Selecting-the-Right-Humanized-Mouse-Model-for-Immuno-Oncology-Programs 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/why-gempharmatech 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/cre-and-reporter-mice 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/genetically-humanized-mice 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/immunodeficient-models 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/disease-models 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/core-research-strains 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/germ-free-mice 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/customized-service/custom-model-generation 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/customized-service/custom-breeding-and-colony-management 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/blogs 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/webinars 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/posters 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/news 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/about-us 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/about-us/global-distributors 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/about-us/careers 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/contact-us 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/blogs/tfrc-humanized-mouse-models-a-preclinical-platform-for-evaluating-bbb-penetrating-alzheimer-s-therapeutics 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/news/undefined 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/strain/fad3t-app-ps1-tau 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/strain/bks-db 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/animal-models/strain/balb-c-nude 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/cookies 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/disclaimers 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/sitemap 2026-07-26T05:16:32+00:00 daily 0.8000 https://www.gempharmatech.com/insights/events/immunology2026 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/events/aacr-2026 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/events/ad-pdtm-2026 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/events/neuroscience-2025 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/ncg 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/apoe-ko-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/apc-min 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/mouse-recommend/genetically-engineered-models 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/advancing-antifungal-drug-development-with-preclinical-fungal-infection-platform 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/applications-of-genetically-engineered-mouse-models-for-hypertrophic-cardiomyopathy-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/respiratory-diseases 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/infectious-diseases 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/infectious-diseases-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/microbiota-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/hupbmc-ncg-mhc-dko-ch 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/hupbmc-ncg-ch 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/huhsc-ncg-ch 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/huhsc-ncg-m-ch 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/mouse-recommend/humanized-immune-system-mice 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/accelerating-t-cell-engager-tce-development-advanced-preclinical-evaluation-solutions 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/overcoming-adc-resistance-construction-and-preclinical-applications-of-enhertu-resistant-models 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-ob 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-chr1-yp1-wild-mouse 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hacvr1c 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hgcgr 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hgipr 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hgipr-v2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hgipr-hgcgr 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hglp-1r 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hinhbe-utr 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/beyond-weight-loss-a-new-paradigm-in-anti-obesity-drug-evaluation 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/nod-shiltjgpt 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/uox-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hrankl 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-alms1-del-c-3802-3812 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-chr1-yp1-hmc4r 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hdgat2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/weight-loss-of-10-within-2-weeks-evaluating-amylin-analogs-in-diet-induced-obese-dio-rat-model 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/rheumatology 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-il10-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/trex1-ko-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/ncg-m-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hbaff 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-c-hairless 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-c-hcd74 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-cd11b-hcd89-fcar 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-cd14-hfcar-cd89-higha1 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/beyond-the-eosinophilic-paradigm-mechanism-driven-selection-of-mouse-models-in-asthma-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/advance-psoriatic-arthritis-drug-discovery-with-a-validated-preclinical-model-for-jaki-and-dexamethasone-testing 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/tnf-delare-lox 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/evaluating-cd20-antibody-efficacy-using-baff-cd20-dual-target-humanized-mice 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/kidney-diseases-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/baff-plus-models-for-sle 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/kidney-diseases 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/respiratory-system 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/gastrointestinal-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/rethinking-asthma-preclinical-models-matching-mouse-models-to-drug-mechanism-across-asthma-phenotypes 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/preclinical-service/nervous-system 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad4t 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b10-dmd-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad2t-app-ps1 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hsnca-a53t-6 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hhtt130-n 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-dmd-del52 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hapoe3 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hapoe4-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hrxfp1 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/ldlr-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/myh6-p-r404q 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-apoe-ko-sr-bi-ct 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-chr1-yp1-apoe-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-chr1-yp1-ldlr-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hagt-h11-hren 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-haplnr 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/advancing-heart-failure-research-a-comprehensive-guide-to-preclinical-hfref-and-hfpef-models 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/a-novel-mouse-model-of-atherosclerosis-for-testing-pcsk9-targeted-therapeutics 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad4t-htrem2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad3t-htrem2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad4t-apoe3 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad4t-apoe4 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad3t-hapoe3 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad3t-hapoe4 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/preclinical-mouse-models-for-reliable-als-therapeutic-insights 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/advancing-alzheimer-s-research-at-aaic-2025-discover-gempharmatech-s-cutting-edge-ad-mouse-models 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-c-htfrc 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/h11-k18-hace2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/ncg-fah-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-c-hcxcr3 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-c-hil4-hil4r-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-c-htslp-v2-htslpr 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-c-htslp-htslpr-hil7r 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/ifnar1-ifngr1-dko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/hace2-extracellular-humanization 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/hace2-all-humanization 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/advancing-respiratory-disease-drug-development-a-comprehensive-mouse-platform-for-translational-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-f8-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/ncg-idua-w392x 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-lat-p-y136f 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-pkd1-flox-cdh16-creert2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/col4a3-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/hfgfr3-g380r 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/ncg-x-f8-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-casr-l723q 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-chmp4c 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/f9-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/mouse-models-bring-hope-for-rare-disease-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/gempharmatech-takes-you-to-understand-the-rare-disease-mucopolysaccharidosis 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/c57bl-6jgpt-germ-free 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-cjgpt-germ-free 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/icr-germ-free 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/human-derived-strain-library 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/mouse-derived-strain-library 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/list-of-peer-reviewed-publications-from-our-clients 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/mouse-models-for-studying-anti-pd-1-resistance 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/advancing-novel-breast-cancer-drug-development-with-her2-adc-resistance-models 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/health-monitoring-program 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/why-gempharmatech/domestic-international-shipping-export-logistics 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/why-gempharmatech/standardized-shipping-protocols 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/why-gempharmatech/standard-animal-receiving-and-acclimation-guidelines 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/tek-icre 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/lgr5-creert2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/lyz2-icre 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/h11-alb-icre 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/mouse-recommend/cre-and-reporter-mice 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hpd1 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-hpcsk9-utr 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-htfrc 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/mouse-recommend/genetically-humanized-mice 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/nod-scid 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6-rag1-ko 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/b6j-dio 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/mouse-recommend/disease-models 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/c57bl-6jgpt 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/balb-cjgpt 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/sd 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/a-jgpt 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/mouse-recommend/core-research-strains 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/mouse-recommend/germ-free-mice 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/expanding-therapeutic-horizons-for-glp-1r-beyond-weight-loss 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/blogs/cardio-kidney-syndrome-models-for-translational-comorbidity-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/establishment-and-pharmacological-evaluation-of-two-temporal-uvb-induced-cle-models-in-trex1-ko-mice-via-cgas-sting-type-i-ifn-pathway 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/enhanced-enhertu-resistant-her2-positive-breast-cancer-models-for-adc-resistance-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/tnfr2-humanized-mice-an-ideal-model-for-studying-anti-tnfr2-antibodies 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/news/gccl-and-gempharmatech-sign-mou-to-advance-global-drug-discovery-and-development-services 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/news/gemPharmatech-and-humlab-global 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/news/gempharmatech-s-san-diego-cro-facility-receives-aaalac-accreditation 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/from-off-the-shelf-to-purpose-built-optimizing-mouse-models-for-mechanistic-and-translational-research 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/expanding-indications-for-glp-1-receptor-targeted-therapies-in-mouse-models-of-metabolic-disease 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/overcoming-challenges-in-the-post-pd-1-era-of-cancer-immunotherapy 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/unlock-the-potential-of-preclinical-als-research-with-advanced-mouse-models 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/webinars/knockout-all-project-koap-genetically-modified-mouse-models-and-their-applications 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/a-novel-preclinical-tool-for-evaluating-cd3-bcma-t-cell-engaging-antibodies-efficacy-based-on-a-spontaneous-systemic-lupus-erythematosus-model 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/preclinical-evaluation-platform-for-mrna-cancer-vaccines-based-on-human-mhc-restricted-immune-response-assessment 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/evaluating-in-vivo-car-t-efficacy-in-humanized-ncg-mhc-dko-mouse-model-with-delayed-gvhd 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/an-integrated-preclinical-platform-for-comprehensive-evaluation-of-t-cell-engagers 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/posters/novel-t-cell-engager-targeting-cd3-and-cdh17-for-the-treatment-of-solid-tumors 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/news/gempharmatech-announces-research-collaboration-with-leading-cancer-center-to-advance-antibody-discovery 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/about-us/careers/business-development-manager-academic 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/about-us/careers/business-development-manager-academic-2 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/about-us/careers/business-development-manager-academic-3 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad3t-htfrc 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/animal-models/strain/fad4t-htfrc 2026-07-26T05:16:32+00:00 daily 0.6400 https://www.gempharmatech.com/insights/events/acr-convergence-2025 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/animal-models/mouse-recommend 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/gempharmatech-mouse-models-support-discovery-in-cell-publication-revealing-a-novel-treg-mediated-mechanism-of-immunotherapy-resistance 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/tce-in-vitro-evaluation-platform-comprehensive-assessment-from-target-engagement-to-tumor-cell-killing 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/world-vitiligo-day-advancing-awareness-and-therapeutic-innovation 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/404 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/unlocking-the-potential-of-antibody-drug-conjugates-gempharmatech-s-comprehensive-in-vitro-evaluation-platform 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/advancing-pvr-research-a-novel-transgenic-mouse-model-with-spontaneous-disease-phenotype 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/fabry-disease-mouse-models-for-preclinical-efficacy-evaluation 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/immune-related-cytotoxicity-evaluation-platform-for-in-vitro-pharmacodynamics 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/overcoming-obesity-challenges-facing-weight-loss-drugs-and-the-promise-of-combination-therapies 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/featured-on-the-cover-of-cell-metabolism-publication-on-cancer-cachexia-supported-by-gempharmatech-s-mouse-models 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/mouse-models-to-unlock-the-secrets-of-aging 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/whisker-wisdom-efficient-blood-glucose-testing-procedures-for-bks-db-mice 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/accelerating-tce-drug-development-with-humanized-mouse-models 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/blogs/new-publications-on-the-mapk-signaling-cascade-using-gempharmatech-mice 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/animal-models/strain/b6-rosa26-hagt 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/animal-models/strain/b6-hhla-a11-1-hb2m 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/animal-models/strain/b6-hfcrn-2 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/animal-models/strain/b6-hmmp7 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/animal-models/strain/dba-1jgpt 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/animal-models/strain/c57bl-6ngpt 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/posters/modeling-of-de-novo-resistance-to-trastuzumab-deruxtecan-in-her2-positive-patient-derived-xenografts 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/posters/preclinical-models-for-evaluating-bispecific-antibodies-targeting-pd-1-and-vegf 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/posters/ncg-m-humanized-mice-an-excellent-model-for-human-immune-reconstitution-of-myeloid-lineages 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/posters/ncg-mhc-dko-mouse-lacks-gvhd-an-ideal-model-for-pbmc-reconstitution-and-pharmacodynamic-evaluation 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/webinars/murine-models-for-heart-failure-research 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/posters/robust-in-vivo-car-t-efficacy-evaluation-in-a-pbmc-reconstituted-ncg-mhc-dko-model-with-delayed-gvhd 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/news/distribution-agreement-provides-japanese-researchers-streamlined-access-to-gempharmatech-s-mouse-models-and-preclinical-services 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/about-us/careers/12 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/about-us/careers/11 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/about-us/careers/13 2026-07-26T05:16:32+00:00 daily 0.5120 https://www.gempharmatech.com/insights/events/sitc-2025 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/blogs/b-cell-depletion-therapy-a-new-approach-to-the-treatment-of-autoimmune-diseases 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/blogs/from-lab-to-clinic-how-rxfp1-humanized-mice-are-paving-the-way-for-next-generation-cardiovascular-therapeutics 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/blogs/new-publication-on-humanized-mouse-tumor-models 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/blogs/2024-brings-great-news-the-fourth-high-quality-article-on-the-fad4t-alzheimer-s-disease-mouse-model-developed-independently-by-gempharmatech-has-been-published 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/blogs/world-parkinson-s-day-2025-advancing-parkinson-s-research-with-cutting-edge-mouse-models 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/posters/novel-preclinical-models-for-evaluating-checkpoint-inhibitor-resistance 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/posters/b6-kras-sup-lsl-g12c-sup-mouse-model-for-assessing-the-occurrence-and-development-of-spontaneous-tumors-in-the-lung 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/posters/analysis-of-selective-response-of-anti-pd-l1-treatment-in-hupbmc-ncg-mice-reconstituted-with-different-donors 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/webinars/preclinical-strategies-to-evaluate-t-cell-engagers 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/news/gempharmatech-strengthens-collaboration-with-japan-s-research-community 2026-07-26T05:16:32+00:00 daily 0.4096 https://www.gempharmatech.com/insights/events/ada-2025 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/blogs/modeling-hypertrophic-cardiomyopathy-next-generation-mouse-models-for-translational-research 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/blogs/shaping-the-future-of-in-vivo-genomic-editing-gempharmatech-s-next-generation-ncg-portfolio 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/blogs/another-high-quality-article-published-using-alzheimer-s-disease-mouse-model-fad4t-from-gempharmatech 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/posters/resistant-mouse-models-for-advancing-third-generation-egfr-tki-drug-development 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/posters/a-novel-mouse-model-for-preclinical-efficacy-evaluation-of-anti-cd3-gprc5d-bispecific-antibodies 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/posters/b7h3-pdl1-double-humanized-balb-c-mouse-a-novel-animal-model-for-preclinical-studies-of-human-b7h3-antibodies-or-bispecific-antibodies 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/webinars/targeted-b-cell-therapies-challenges-and-preclinical-evaluation-considerations-for-repurposing-from-oncology-to-autoimmunity 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/news/gempharmatech-and-setsuro-tech-announce-distributor-agreement-to-support-japanese-biomedical-research-community 2026-07-26T05:16:32+00:00 daily 0.3277 https://www.gempharmatech.com/insights/events/eacr-2025 2026-07-26T05:16:32+00:00 daily 0.2621 https://www.gempharmatech.com/insights/blogs/nafld-is-now-masld-why-has-this-disease-been-renamed 2026-07-26T05:16:32+00:00 daily 0.2621 https://www.gempharmatech.com/insights/posters/advancing-translational-models-of-cancer-cachexia-for-preclinical-to-clinical-integration 2026-07-26T05:16:32+00:00 daily 0.2621 https://www.gempharmatech.com/insights/posters/breaking-through-adcs-resistance-constructing-preclinical-enhertu-induced-resistant-model 2026-07-26T05:16:32+00:00 daily 0.2621 https://www.gempharmatech.com/insights/posters/ncg-hil2-mice-a-novel-model-to-support-the-development-of-t-regulatory-and-nk-cells 2026-07-26T05:16:32+00:00 daily 0.2621 https://www.gempharmatech.com/insights/webinars/drug-resistance-models-in-mice-mechanisms-establishment-and-applications 2026-07-26T05:16:32+00:00 daily 0.2621 https://www.gempharmatech.com/insights/news/gempharmatech-significantly-expands-u-s-capabilities-with-new-san-diego-biotech-hub-facility 2026-07-26T05:16:32+00:00 daily 0.2621 https://www.gempharmatech.com/insights/events/4th-world-adc-asia-summit 2026-07-26T05:16:32+00:00 daily 0.2097 https://www.gempharmatech.com/insights/blogs/world-hepatitis-day 2026-07-26T05:16:32+00:00 daily 0.2097 https://www.gempharmatech.com/insights/posters/development-of-novel-ncg-hil15-and-hil2-mouse-models-for-preclinical-assessment-of-human-nk-cell-function 2026-07-26T05:16:32+00:00 daily 0.2097 https://www.gempharmatech.com/insights/posters/balb-c-hil12rb1-hil12rb2-a-robust-model-for-preclinical-research-in-human-il-12-therapy 2026-07-26T05:16:32+00:00 daily 0.2097 https://www.gempharmatech.com/insights/posters/allograft-and-xenograft-gvhd-mouse-models-for-efficacy-evaluation-of-anti-gvhd-drugs-and-research-in-immunoregulation 2026-07-26T05:16:32+00:00 daily 0.2097 https://www.gempharmatech.com/insights/webinars/developing-robust-preclinical-evaluation-strategies-for-t-cell-engagers-tces-accelerating-development-and-reducing-translational-risks 2026-07-26T05:16:32+00:00 daily 0.2097 https://www.gempharmatech.com/insights/news/gempharmatech-joins-shonan-health-innovation-park-expanding-and-strengthening-research-support-in-japan 2026-07-26T05:16:32+00:00 daily 0.2097 https://www.gempharmatech.com/insights/events/16th-felasa-congress 2026-07-26T05:16:32+00:00 daily 0.1678 https://www.gempharmatech.com/insights/blogs/ag129-mice-to-help-dengue-virus-related-research 2026-07-26T05:16:32+00:00 daily 0.1678 https://www.gempharmatech.com/insights/posters/enhanced-human-immune-system-engraftment-in-a-novel-triple-engineered-ncg-mtslp-hil6-mflt3-ko-mouse-model-2 2026-07-26T05:16:32+00:00 daily 0.1678 https://www.gempharmatech.com/insights/posters/development-and-application-of-the-ncg-hil2-mouse-model-a-humanized-platform-for-enhanced-nk-cell-evaluation-in-adcc-efficacy-testing 2026-07-26T05:16:32+00:00 daily 0.1678 https://www.gempharmatech.com/insights/posters/ncg-hil15-mice-an-ideal-model-for-human-immune-reconstitution-of-nk-cells 2026-07-26T05:16:32+00:00 daily 0.1678 https://www.gempharmatech.com/insights/webinars/latest-technology-advances-in-antibody-drug-discovery-2 2026-07-26T05:16:32+00:00 daily 0.1678 https://www.gempharmatech.com/insights/news/gempharmatech-and-goodwill-announce-strategic-partnership-to-advance-ai-driven-pdx-model-ecosystem-for-cancer-drug-development 2026-07-26T05:16:32+00:00 daily 0.1678 https://www.gempharmatech.com/insights/events/faobmb-2025 2026-07-26T05:16:32+00:00 daily 0.1342 https://www.gempharmatech.com/insights/blogs/how-humanized-mouse-models-can-help-develop-new-treatments-for-hbv 2026-07-26T05:16:32+00:00 daily 0.1342 https://www.gempharmatech.com/insights/posters/a-novel-humanized-mouse-model-for-preclinical-assessment-of-anti-cd47-and-anti-sirp-therapeutics 2026-07-26T05:16:32+00:00 daily 0.1342 https://www.gempharmatech.com/insights/posters/development-of-a-novel-murine-model-ncg-m-hil15-for-enhanced-post-hsc-transplantation-immunoreconstruction 2026-07-26T05:16:32+00:00 daily 0.1342 https://www.gempharmatech.com/insights/posters/preclinical-service-capability-in-efficacy-evaluation-of-adcs 2026-07-26T05:16:32+00:00 daily 0.1342 https://www.gempharmatech.com/insights/webinars/mouse-models-and-pharmacology-services-for-neurological-disease-research 2026-07-26T05:16:32+00:00 daily 0.1342 https://www.gempharmatech.com/insights/news/gempharmatech-named-one-of-china-s-top-100-life-science-service-brands-for-2024 2026-07-26T05:16:32+00:00 daily 0.1342 https://www.gempharmatech.com/insights/events/asgct-28th-annual-meeting 2026-07-26T05:16:32+00:00 daily 0.1074 https://www.gempharmatech.com/insights/blogs/beyond-the-scars-exploring-multiple-sclerosis 2026-07-26T05:16:32+00:00 daily 0.1074 https://www.gempharmatech.com/insights/posters/bridging-in-vitro-screening-to-in-vivo-efficacy-for-cancer-vaccines 2026-07-26T05:16:32+00:00 daily 0.1074 https://www.gempharmatech.com/insights/posters/patient-derived-xenograft-pdx-models-with-differential-her2-expression-for-preclinical-evaluation-of-her2-targeted-therapies 2026-07-26T05:16:32+00:00 daily 0.1074 https://www.gempharmatech.com/insights/posters/a-novel-alzheimer-s-disease-mouse-model-with-earlier-a-accumulation-and-later-onset-of-cognitive-impairments 2026-07-26T05:16:32+00:00 daily 0.1074 https://www.gempharmatech.com/insights/webinars/mouse-models-of-metabolic-diseases-and-their-applications-from-disease-research-to-drug-development 2026-07-26T05:16:32+00:00 daily 0.1074 https://www.gempharmatech.com/insights/news/gempharmatech-leads-global-collaboration-dialogue-at-biochina-forum-in-san-diego 2026-07-26T05:16:32+00:00 daily 0.1074 https://www.gempharmatech.com/insights/events/bio-korea-2025 2026-07-26T05:16:32+00:00 daily 0.0859 https://www.gempharmatech.com/insights/blogs/2023-world-alzheimer-s-day 2026-07-26T05:16:32+00:00 daily 0.0859 https://www.gempharmatech.com/insights/posters/humanized-fcrn-mouse-model-a-superior-platform-for-predicting-human-pk-of-therapeutic-antibodies 2026-07-26T05:16:32+00:00 daily 0.0859 https://www.gempharmatech.com/insights/posters/neomabtm-a-novel-platform-for-fully-human-therapeutic-antibody-development 2026-07-26T05:16:32+00:00 daily 0.0859 https://www.gempharmatech.com/insights/posters/novel-orthotopic-pancreatic-cancer-cell-lines-with-kras-g12d-mutation-derived-from-c57bl-6-kpc-mice 2026-07-26T05:16:32+00:00 daily 0.0859 https://www.gempharmatech.com/insights/webinars/applications-of-humanized-mice-in-the-evaluation-of-antibody-drug-conjugates-to-treat-autoimmune-diseases 2026-07-26T05:16:32+00:00 daily 0.0859 https://www.gempharmatech.com/insights/news/gempharmatech-s-board-appoints-brandy-wilkinson-ph-d-as-its-new-chief-executive-officer-of-gempharmatech-corporation 2026-07-26T05:16:32+00:00 daily 0.0859 https://www.gempharmatech.com/insights/events/aacr-2025 2026-07-26T05:16:32+00:00 daily 0.0687 https://www.gempharmatech.com/insights/blogs/breast-cancer-awareness-month 2026-07-26T05:16:32+00:00 daily 0.0687 https://www.gempharmatech.com/insights/posters/murine-models-of-bone-and-brain-metastasis-for-preclinical-cancer-research 2026-07-26T05:16:32+00:00 daily 0.0687 https://www.gempharmatech.com/insights/posters/preclinical-pd-1-resistance-models-crucial-tools-for-unveiling-pd-1-resistance-mechanisms-and-advancing-novel-treatment-strategies 2026-07-26T05:16:32+00:00 daily 0.0687 https://www.gempharmatech.com/insights/posters/humanized-mice-model-for-efficacy-and-toxicity-evaluation-of-drugs-targeting-cd47-sirp-pd1-pd-l1-axes 2026-07-26T05:16:32+00:00 daily 0.0687 https://www.gempharmatech.com/insights/webinars/modeling-autoimmune-diseases-utilizing-mice-with-humanized-immune-systems 2026-07-26T05:16:32+00:00 daily 0.0687 https://www.gempharmatech.com/insights/news/gempharmatech-launches-new-site-and-research-platform-in-shanghai-baoshan-base 2026-07-26T05:16:32+00:00 daily 0.0687 https://www.gempharmatech.com/insights/events/8th-car-tcr-summit-europe 2026-07-26T05:16:32+00:00 daily 0.0550 https://www.gempharmatech.com/insights/blogs/rare-disease-day-2024-models-to-effect-change 2026-07-26T05:16:32+00:00 daily 0.0550 https://www.gempharmatech.com/insights/posters/a-novel-mouse-colitis-model-recapitulating-human-t-cell-and-myeloid-cell-reconstitution-to-support-drug-evaluation-in-inflammatory-bowel-disease 2026-07-26T05:16:32+00:00 daily 0.0550 https://www.gempharmatech.com/insights/posters/efficacy-evaluation-of-b-cell-targeting-drug-candidates-using-humanized-baff-transgenic-sle-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0550 https://www.gempharmatech.com/insights/posters/humanized-cd3edg-mice-an-ideal-model-to-study-the-efficacy-of-cd3-bispecific-antibodies 2026-07-26T05:16:32+00:00 daily 0.0550 https://www.gempharmatech.com/insights/webinars/biological-functions-of-migrasomes 2026-07-26T05:16:32+00:00 daily 0.0550 https://www.gempharmatech.com/insights/news/gempharmatech-co-ltd-opens-new-operations-in-united-states-to-house-more-than-6000-research-mouse-models 2026-07-26T05:16:32+00:00 daily 0.0550 https://www.gempharmatech.com/insights/events/nextgen-biomed-2025 2026-07-26T05:16:32+00:00 daily 0.0440 https://www.gempharmatech.com/insights/blogs/world-pancreatic-cancer-day 2026-07-26T05:16:32+00:00 daily 0.0440 https://www.gempharmatech.com/insights/posters/lps-hdm-induced-asthma-model-a-translational-platform-for-neutrophilic-asthma-and-glucocorticoid-resistant-inflammation 2026-07-26T05:16:32+00:00 daily 0.0440 https://www.gempharmatech.com/insights/posters/phenotypic-and-therapeutic-evaluation-of-humanized-c3-transgenic-mice-as-a-model-for-c3-glomerulopathy-like-autoimmune-disease 2026-07-26T05:16:32+00:00 daily 0.0440 https://www.gempharmatech.com/insights/posters/a-humanized-pd-1-lag-3-dual-immune-checkpoint-knock-in-mouse-model-for-preclinical-evaluation-of-combination-anti-pd-1-lag-3-therapy 2026-07-26T05:16:32+00:00 daily 0.0440 https://www.gempharmatech.com/insights/webinars/germ-free-mouse-models-and-their-applications-in-microbiome-related-research 2026-07-26T05:16:32+00:00 daily 0.0440 https://www.gempharmatech.com/insights/news/sars-cov-2-mpro-inhibitors-with-antiviral-activity-in-a-transgenic-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0440 https://www.gempharmatech.com/insights/events/tumour-models-summit-nordics 2026-07-26T05:16:32+00:00 daily 0.0352 https://www.gempharmatech.com/insights/blogs/world-psoriasis-day-gempharmatech-embrace-your-skin 2026-07-26T05:16:32+00:00 daily 0.0352 https://www.gempharmatech.com/insights/posters/therapeutic-evaluation-of-a-c3-targeting-small-nucleic-acid-drug-in-a-spontaneous-humanized-c3-glomerulopathy-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0352 https://www.gempharmatech.com/insights/posters/development-and-characterization-of-ncg-x-mouse-model-for-gene-therapy-in-erythroid-disorders 2026-07-26T05:16:32+00:00 daily 0.0352 https://www.gempharmatech.com/insights/posters/cd34-humanized-huhsc-ncg-mice-engrafted-with-hematological-malignancies-models-for-preclinical-study-of-anti-human-cd19-therapeutic-antibodies 2026-07-26T05:16:32+00:00 daily 0.0352 https://www.gempharmatech.com/insights/webinars/genome-rewriting-generates-mouse-models-of-human-diseases 2026-07-26T05:16:32+00:00 daily 0.0352 https://www.gempharmatech.com/insights/news/gempharmatech-and-uc-davis-sign-agreement-to-distribute-mouse-models-in-the-us-to-better-serve-us-academic-and-pre-clinical-r-d-communities 2026-07-26T05:16:32+00:00 daily 0.0352 https://www.gempharmatech.com/insights/events/tumour-models-london-summit 2026-07-26T05:16:32+00:00 daily 0.0281 https://www.gempharmatech.com/insights/blogs/world-osteoporosis-day-making-the-silent-killer-visible 2026-07-26T05:16:32+00:00 daily 0.0281 https://www.gempharmatech.com/insights/posters/development-and-therapeutic-evaluation-of-a-uniform-lymph-node-cell-transfer-model-of-alopecia-areata 2026-07-26T05:16:32+00:00 daily 0.0281 https://www.gempharmatech.com/insights/posters/novel-animal-models-to-evaluate-preclinical-studies-of-thalassemia 2026-07-26T05:16:32+00:00 daily 0.0281 https://www.gempharmatech.com/insights/posters/cd137-humanized-mice-for-preclinical-efficacy-evaluation-of-anti-cd137-therapeutic-antibodies 2026-07-26T05:16:32+00:00 daily 0.0281 https://www.gempharmatech.com/insights/webinars/immune-mediated-nephropathy-selection-and-application-of-mouse-models 2026-07-26T05:16:32+00:00 daily 0.0281 https://www.gempharmatech.com/insights/news/gempharmatech-presents-humanized-mouse-models-to-support-bispecific-antibody-and-covid-19-preclinic-development-at-biologics-uk-oxford-global-conference 2026-07-26T05:16:32+00:00 daily 0.0281 https://www.gempharmatech.com/insights/events/mbsj-2024 2026-07-26T05:16:32+00:00 daily 0.0225 https://www.gempharmatech.com/insights/blogs/world-arthritis-day-let-mouse-models-guard-your-joint-health 2026-07-26T05:16:32+00:00 daily 0.0225 https://www.gempharmatech.com/insights/posters/unveiling-fad3t-a-groundbreaking-transgenic-mouse-model-for-accelerating-alzheimer-s-disease-research 2026-07-26T05:16:32+00:00 daily 0.0225 https://www.gempharmatech.com/insights/posters/a-preclinical-mouse-model-for-evaluating-therapeutic-approaches-to-hemophilia-a 2026-07-26T05:16:32+00:00 daily 0.0225 https://www.gempharmatech.com/insights/posters/balb-c-mice-with-humanized-vista-a-novel-gemm-for-preclinical-evaluation-of-therapeutic-antibodies-against-vista 2026-07-26T05:16:32+00:00 daily 0.0225 https://www.gempharmatech.com/insights/webinars/The%20application%20of%20transgenic%20mice%20in%20drug%20safety%20evaluation 2026-07-26T05:16:32+00:00 daily 0.0225 https://www.gempharmatech.com/insights/news/gempharmatech-us-launches-new-website 2026-07-26T05:16:32+00:00 daily 0.0225 https://www.gempharmatech.com/insights/events/acr-convergence-2024 2026-07-26T05:16:32+00:00 daily 0.0180 https://www.gempharmatech.com/insights/blogs/understanding-hypertension-exploring-animal-models-for-research 2026-07-26T05:16:32+00:00 daily 0.0180 https://www.gempharmatech.com/insights/posters/construction-and-pharmacological-evaluation-of-a-new-parkinson-s-disease-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0180 https://www.gempharmatech.com/insights/posters/neomab-a-novel-platform-for-fully-human-therapeutic-antibody-development 2026-07-26T05:16:32+00:00 daily 0.0180 https://www.gempharmatech.com/insights/posters/balb-c-hpd1-hgitr-a-novel-mouse-model-for-preclinical-evaluation-of-anti-gitr-and-anti-pd1-therapies 2026-07-26T05:16:32+00:00 daily 0.0180 https://www.gempharmatech.com/insights/webinars/NeoMab®:%20An%20Integrated%20Platform%20to%20Accelerate%20Fully%20Human%20Antibody%20Drug%20Discovery 2026-07-26T05:16:32+00:00 daily 0.0180 https://www.gempharmatech.com/insights/news/lji-and-charles-river-laboratories-to-collaborate-on-covid-19-research 2026-07-26T05:16:32+00:00 daily 0.0180 https://www.gempharmatech.com/insights/events/sitc-2024 2026-07-26T05:16:32+00:00 daily 0.0144 https://www.gempharmatech.com/insights/blogs/unleashing-the-potential-of-small-interfering-rna-drugs-a-revolutionary-approach-to-precision-medicine 2026-07-26T05:16:32+00:00 daily 0.0144 https://www.gempharmatech.com/insights/posters/next-generation-mouse-models-for-t-cell-engager-preclinical-evaluation 2026-07-26T05:16:32+00:00 daily 0.0144 https://www.gempharmatech.com/insights/posters/patient-derived-xenograft-pdx-models-with-varying-levels-of-her2-expression-are-utilized-for-the-preclinical-evaluation-of-her2-targeted-therapies 2026-07-26T05:16:32+00:00 daily 0.0144 https://www.gempharmatech.com/insights/posters/impreved-humanized-mouse-models-for-preclinical-efficacy-evaluation-of-drugs-targeting-cd73 2026-07-26T05:16:32+00:00 daily 0.0144 https://www.gempharmatech.com/insights/webinars/Genome-Modified%20Cardiovascular%20Disease%20Models%20in%20GemPharmatech%20and%20Their%20Applications 2026-07-26T05:16:32+00:00 daily 0.0144 https://www.gempharmatech.com/insights/news/moving-from-discovery-to-clinic-with-genetically-engineered-mouse-models 2026-07-26T05:16:32+00:00 daily 0.0144 https://www.gempharmatech.com/insights/events/cell-2024 2026-07-26T05:16:32+00:00 daily 0.0115 https://www.gempharmatech.com/insights/blogs/inflammatory-bowel-disease-a-prime-time-for-new-drug-development 2026-07-26T05:16:32+00:00 daily 0.0115 https://www.gempharmatech.com/insights/posters/development-of-fully-human-cd98hc-antibodies-to-enhance-delivery-of-therapeutic-drugs-across-the-blood-brain-barrier 2026-07-26T05:16:32+00:00 daily 0.0115 https://www.gempharmatech.com/insights/posters/a-mouse-model-of-gvhd-for-evaluating-the-preclinical-efficacy-of-anti-gvhd-drugs 2026-07-26T05:16:32+00:00 daily 0.0115 https://www.gempharmatech.com/insights/posters/development-of-an-fc-gamma-receptor-fully-humanized-mouse-model-to-support-the-accurate-preclinical-study-of-therapeutic-antibodies 2026-07-26T05:16:32+00:00 daily 0.0115 https://www.gempharmatech.com/insights/webinars/mash-models-and-its-application-in-candidate-drug-screening-for-metabolic-syndrome-and-hepatic-steatosis 2026-07-26T05:16:32+00:00 daily 0.0115 https://www.gempharmatech.com/insights/news/recent-publication-in-mammalian-genomics 2026-07-26T05:16:32+00:00 daily 0.0115 https://www.gempharmatech.com/insights/events/pegs-europe 2026-07-26T05:16:32+00:00 daily 0.0092 https://www.gempharmatech.com/insights/blogs/breaking-barriers-advancing-gene-therapies-for-amyotrophic-lateral-sclerosis 2026-07-26T05:16:32+00:00 daily 0.0092 https://www.gempharmatech.com/insights/posters/a-novel-patient-derived-pre-clinical-mouse-model-for-myasthenia-gravis 2026-07-26T05:16:32+00:00 daily 0.0092 https://www.gempharmatech.com/insights/posters/humanized-mouse-models-for-preclinical-efficacy-evaluation-of-adcs 2026-07-26T05:16:32+00:00 daily 0.0092 https://www.gempharmatech.com/insights/webinars/considering-drug-moa-when-selecting-sle-mouse-models-for-preclinical-efficacy-studies 2026-07-26T05:16:32+00:00 daily 0.0092 https://www.gempharmatech.com/insights/news/gempharmatech-leading-provider-of-genetically-engineered-mouse-models-goes-public-on-shanghai-stock-exchange 2026-07-26T05:16:32+00:00 daily 0.0092 https://www.gempharmatech.com/insights/events/bio-europe 2026-07-26T05:16:32+00:00 daily 0.0074 https://www.gempharmatech.com/insights/blogs/breathing-new-life-into-idiopathic-pulmonary-fibrosis-advances-in-understanding-a-complex-lung-disease 2026-07-26T05:16:32+00:00 daily 0.0074 https://www.gempharmatech.com/insights/posters/integrated-platforms-for-the-preclinical-evaluation-of-t-cell-engagers 2026-07-26T05:16:32+00:00 daily 0.0074 https://www.gempharmatech.com/insights/posters/krasflex-g12c-a-novel-mouse-model-for-the-study-of-spontaneous-tumors-and-adenocarcinomas-of-the-lung 2026-07-26T05:16:32+00:00 daily 0.0074 https://www.gempharmatech.com/insights/webinars/human-immune-reconstituted-mice-in-translational-medicine-challenges-and-solutions 2026-07-26T05:16:32+00:00 daily 0.0074 https://www.gempharmatech.com/insights/news/gempharmatech-and-charles-river-laboratories-sign-exclusive-agreement-to-distribute-next-generation-ncg-portfolio 2026-07-26T05:16:32+00:00 daily 0.0074 https://www.gempharmatech.com/insights/events/the-korean-society-of-nonclinical-study-46th-workshop 2026-07-26T05:16:32+00:00 daily 0.0059 https://www.gempharmatech.com/insights/blogs/world-lymphoma-awareness-day-gempharmatech-provides-mouse-models-for-lymphoma-research 2026-07-26T05:16:32+00:00 daily 0.0059 https://www.gempharmatech.com/insights/posters/development-of-preclinical-anti-pd-1-resistant-models-to-uncover-mechanisms-of-immune-evasion 2026-07-26T05:16:32+00:00 daily 0.0059 https://www.gempharmatech.com/insights/posters/ncg-m-humanized-mice-a-model-for-human-immune-reconstitution-of-myeloid-lineages 2026-07-26T05:16:32+00:00 daily 0.0059 https://www.gempharmatech.com/insights/webinars/preclinical-study-on-human-nk-related-in-humanized-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0059 https://www.gempharmatech.com/insights/events/eacr-conference-cancer-metabolism 2026-07-26T05:16:32+00:00 daily 0.0047 https://www.gempharmatech.com/insights/blogs/exploring-rheumatoid-arthritis-and-its-complexities 2026-07-26T05:16:32+00:00 daily 0.0047 https://www.gempharmatech.com/insights/posters/ncg-hil15-and-ncg-hil2-mice-excellent-models-for-human-immune-reconstitution-of-nk-cells 2026-07-26T05:16:32+00:00 daily 0.0047 https://www.gempharmatech.com/insights/posters/ncg-mhc-dko-mouse-model-an-ideal-model-for-pbmc-reconstitution-and-pharmacodynamic-evaluation-in-the-absence-of-gvhd 2026-07-26T05:16:32+00:00 daily 0.0047 https://www.gempharmatech.com/insights/webinars/koap-genetically-modified-mouse-models-and-applications 2026-07-26T05:16:32+00:00 daily 0.0047 https://www.gempharmatech.com/insights/events/biojapan-2024 2026-07-26T05:16:32+00:00 daily 0.0038 https://www.gempharmatech.com/insights/blogs/world-duchenne-awareness-day 2026-07-26T05:16:32+00:00 daily 0.0038 https://www.gempharmatech.com/insights/posters/application-of-psoriatic-arthritis-mouse-models-in-preclinical-pharmacodynamic-evaluation 2026-07-26T05:16:32+00:00 daily 0.0038 https://www.gempharmatech.com/insights/posters/preclinical-evaluation-of-the-b7-h3-antibody-in-a-humanized-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0038 https://www.gempharmatech.com/insights/webinars/mouse-models-with-a-chromosome-derived-from-wild-mice 2026-07-26T05:16:32+00:00 daily 0.0038 https://www.gempharmatech.com/insights/events/international-conference-of-the-korean-society-for-molecular-and-cellular-biology-2024 2026-07-26T05:16:32+00:00 daily 0.0030 https://www.gempharmatech.com/insights/blogs/navigating-multiple-sclerosis-from-clinical-management-to-preclinical-research 2026-07-26T05:16:32+00:00 daily 0.0030 https://www.gempharmatech.com/insights/posters/phenotypic-and-transcriptomic-divergence-in-c3-glomerular-mouse-models-insights-into-immune-and-clinical-sex-correlates 2026-07-26T05:16:32+00:00 daily 0.0030 https://www.gempharmatech.com/insights/posters/reconstitution-of-human-t-regulatory-and-nk-cells-in-a-novel-il2-humanized-ncg-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0030 https://www.gempharmatech.com/insights/webinars/Animal%20Models%20for%20Neurodegenerative%20Diseases:%20An%20Introduction%20to%20AD%20and%20PD%20Mouse%20Models 2026-07-26T05:16:32+00:00 daily 0.0030 https://www.gempharmatech.com/insights/events/embl-symposium-defining-and-defeating-metastasis 2026-07-26T05:16:32+00:00 daily 0.0024 https://www.gempharmatech.com/insights/blogs/pcr-aerosol-contamination-causes-consequences-and-solutions 2026-07-26T05:16:32+00:00 daily 0.0024 https://www.gempharmatech.com/insights/posters/a-novel-preclinical-tool-for-evaluating-cd20-antibody-efficacy-based-on-baff-cd20-dual-target-humanized-mice 2026-07-26T05:16:32+00:00 daily 0.0024 https://www.gempharmatech.com/insights/posters/the-gpt-hsod1-g93a-mouse-model-can-recapitulate-progressive-als-like-phenotypes 2026-07-26T05:16:32+00:00 daily 0.0024 https://www.gempharmatech.com/insights/webinars/kpc-mouse-model-and-cell-line-for-pancreatic-cancer-therapy-research 2026-07-26T05:16:32+00:00 daily 0.0024 https://www.gempharmatech.com/insights/events/11th-helmholtz-diabetes-conference 2026-07-26T05:16:32+00:00 daily 0.0019 https://www.gempharmatech.com/insights/blogs/cracking-the-code-of-intestinal-cancer-the-apc-gene-connection 2026-07-26T05:16:32+00:00 daily 0.0019 https://www.gempharmatech.com/insights/posters/a-novel-humanized-mouse-model-for-preclinical-efficacy-evaluation-of-anti-cd47-anti-sirp-therapeutics 2026-07-26T05:16:32+00:00 daily 0.0019 https://www.gempharmatech.com/insights/posters/a-mouse-model-for-inflammatory-bowel-disease-based-on-dss-induced-ncg-m-mice-reconstituted-with-human-hematopoietic-stem-cells 2026-07-26T05:16:32+00:00 daily 0.0019 https://www.gempharmatech.com/insights/webinars/protein-o-glcnacylation-a-sweet-weep-sweep-for-helminth-expulsion 2026-07-26T05:16:32+00:00 daily 0.0019 https://www.gempharmatech.com/insights/events/nordic-life-science-days-2024 2026-07-26T05:16:32+00:00 daily 0.0015 https://www.gempharmatech.com/insights/blogs/unlocking-the-potential-of-ccr8-a-rising-star-in-cancer-immunotherapy 2026-07-26T05:16:32+00:00 daily 0.0015 https://www.gempharmatech.com/insights/posters/enhanced-human-immune-system-engraftment-in-a-novel-triple-engineered-ncg-mtslp-hil6-mflt3-ko-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0015 https://www.gempharmatech.com/insights/posters/b6-chr1km-a-novel-mouse-model-for-spontaneous-nash-research 2026-07-26T05:16:32+00:00 daily 0.0015 https://www.gempharmatech.com/insights/webinars/the-challenges-and-strategies-of-nk-cell-related-io-therapy-in-preclinical-drug-evaluation 2026-07-26T05:16:32+00:00 daily 0.0015 https://www.gempharmatech.com/insights/events/esmo-congress-2024 2026-07-26T05:16:32+00:00 daily 0.0012 https://www.gempharmatech.com/insights/blogs/the-battle-of-the-bulge-targeting-mc4r-for-obesity-treatment 2026-07-26T05:16:32+00:00 daily 0.0012 https://www.gempharmatech.com/insights/posters/semaglutide-and-lisinopril-exerts-therapeutic-benefits-in-a-genetically-engineered-diabetic-nephropathy-mouse-model 2026-07-26T05:16:32+00:00 daily 0.0012 https://www.gempharmatech.com/insights/posters/tirzepatide-and-efruxifermin-demonstrate-therapeutic-benefits-for-nash-in-a-preclinical-metabolic-syndrome-animal-model-b6-alms1-del-mice 2026-07-26T05:16:32+00:00 daily 0.0012 https://www.gempharmatech.com/insights/webinars/preclinical-evaluation-of-car-t-immunotherapies-using-novel-animal-models 2026-07-26T05:16:32+00:00 daily 0.0012 https://www.gempharmatech.com/insights/events/models-and-insights-in-translational-research 2026-07-26T05:16:32+00:00 daily 0.0010 https://www.gempharmatech.com/insights/blogs/faqs-on-the-ibd-model-insights-and-answers 2026-07-26T05:16:32+00:00 daily 0.0010 https://www.gempharmatech.com/insights/posters/a-persistent-hypertension-model-developed-on-the-agt-humanized-mice 2026-07-26T05:16:32+00:00 daily 0.0010 https://www.gempharmatech.com/insights/posters/a-novel-humanized-rheumatoid-arthritis-mice-model-for-therapeutic-assessment 2026-07-26T05:16:32+00:00 daily 0.0010 https://www.gempharmatech.com/insights/webinars/Creating%20Translationally%20Relevant%20Models%20for%20Immunotherapy%20Research:%20A%20Closer%20Look%20at%20Humanized%20FcgR%20Mice 2026-07-26T05:16:32+00:00 daily 0.0010 https://www.gempharmatech.com/insights/events/26th-asia-pacific-league-of-associations-for-rheumatology-congress 2026-07-26T05:16:32+00:00 daily 0.0008 https://www.gempharmatech.com/insights/blogs/gpt-s-fully-human-antibody-transgenic-mouse-neomab 2026-07-26T05:16:32+00:00 daily 0.0008 https://www.gempharmatech.com/insights/posters/development-of-preclinical-models-for-the-evaluation-of-conventional-and-in-vivo-car-t-therapies-2 2026-07-26T05:16:32+00:00 daily 0.0008 https://www.gempharmatech.com/insights/posters/establishment-of-bleomycin-induced-scleroderma-mouse-model-on-hsc-ncg-il15-humanized-mice 2026-07-26T05:16:32+00:00 daily 0.0008 https://www.gempharmatech.com/insights/webinars/immunodeficient-mouse-models-for-cancer-and-immunotherapy-research-ncg-and-next-generation-ncg-mice 2026-07-26T05:16:32+00:00 daily 0.0008 https://www.gempharmatech.com/insights/events/bio-asia-taiwan-2024 2026-07-26T05:16:32+00:00 daily 0.0006 https://www.gempharmatech.com/insights/blogs/unlocking-the-secrets-of-aging 2026-07-26T05:16:32+00:00 daily 0.0006 https://www.gempharmatech.com/insights/posters/ncg-x-a-novel-mouse-model-for-preclinical-studies-evaluating-humanized-erythroid-reconstitution 2026-07-26T05:16:32+00:00 daily 0.0006 https://www.gempharmatech.com/insights/posters/humanized-baff-transgenic-mice-develop-autoimmune-manifestations 2026-07-26T05:16:32+00:00 daily 0.0006 https://www.gempharmatech.com/insights/webinars/fad4t-a-mouse-model-for-alzheimer-s-and-other-neurodegenerative-diseases 2026-07-26T05:16:32+00:00 daily 0.0006 https://www.gempharmatech.com/insights/events/interphex-week-tokyo 2026-07-26T05:16:32+00:00 daily 0.0005 https://www.gempharmatech.com/insights/blogs/glp-1r-a-promising-therapeutic-target-in-diabetes-research 2026-07-26T05:16:32+00:00 daily 0.0005 https://www.gempharmatech.com/insights/posters/mhc-knock-in-mouse-models-for-preclinical-evaluation-of-cancer-mrna-vaccines 2026-07-26T05:16:32+00:00 daily 0.0005 https://www.gempharmatech.com/insights/posters/phenotypic-validation-of-humanized-iga1-and-cd89-transgenic-mice-as-a-model-for-iga-nephropathy-like-autoimmune-disease 2026-07-26T05:16:32+00:00 daily 0.0005 https://www.gempharmatech.com/insights/webinars/germ-free-mice-for-microbiome-research-and-drug-development 2026-07-26T05:16:32+00:00 daily 0.0005 https://www.gempharmatech.com/insights/events/international-vascular-biology-meeting-2024 2026-07-26T05:16:32+00:00 daily 0.0004 https://www.gempharmatech.com/insights/blogs/sentinel-mice-and-their-role-in-microbiological-monitoring 2026-07-26T05:16:32+00:00 daily 0.0004 https://www.gempharmatech.com/insights/posters/applications-for-sle-patient-derived-pbmc-induced-mouse-model-in-preclinical-pharmacological-studies 2026-07-26T05:16:32+00:00 daily 0.0004 https://www.gempharmatech.com/insights/posters/balb-c-hil12rb1-hil12rb2-serves-as-a-robust-mouse-model-to-evaluate-novel-human-il-12-therapeutics 2026-07-26T05:16:32+00:00 daily 0.0004 https://www.gempharmatech.com/insights/webinars/koap-genetically-modified-mouse-models-and-their-applications 2026-07-26T05:16:32+00:00 daily 0.0004 https://www.gempharmatech.com/insights/events/aacr-annual-meeting-2024 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/blogs/atopic-dermatitis-research-understanding-the-disease-and-its-need-for-mouse-models 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/posters/repurposing-oncology-drugs-to-treat-autoimmune-diseases 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/posters/an-improved-pbmc-humanized-xenograft-model-for-preclinical-evaluation-of-immune-checkpoint-inhibitors 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/events/fens-forum-2024 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/blogs/bones-under-stress-mouse-models-for-studying-osteoporosis 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/posters/mouse-models-of-anti-pd-1-resistance-reveals-insights-into-resistance-mechanisms-2 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/posters/development-of-a-novel-murine-model-ncg-m-hil15-for-enhanced-post-hsc-transplantation-immunoreconstruction-2 2026-07-26T05:16:32+00:00 daily 0.0003 https://www.gempharmatech.com/insights/events/71st-jalas 2026-07-26T05:16:32+00:00 daily 0.0002 https://www.gempharmatech.com/insights/blogs/from-mice-to-men-how-animal-models-help-us-to-understand-hypertrophic-cardiomyopathy 2026-07-26T05:16:32+00:00 daily 0.0002 https://www.gempharmatech.com/insights/posters/one-stop-solution-for-preclinical-evaluation-systems-for-bispecific-t-cell-engagers 2026-07-26T05:16:32+00:00 daily 0.0002 https://www.gempharmatech.com/insights/posters/ncg-xm-humanized-mice-an-improved-model-for-human-hsc-immune-reconstitution-without-irradiation 2026-07-26T05:16:32+00:00 daily 0.0002